Engineering signal transduction for closed-loop gene and cell therapies

Abstract Chronic diseases are still treated largely with interventions that are constitutive, intermittently administered and poorly aligned with real-time physiology. Synthetic biology is changing this paradigm by treating gene circuits as programmable genetic software that can be deployed across cellular therapeutic hardware spanning from prokaryotic to eukaryotic systems, including probiotic cells, designer cells, immune cells and stem‑cell‑derived platforms. In this framework, engineered systems can sense disease-associated signals, compute them through synthetic or repurposed transduction pathways and adjust therapeutic output to maintain physiological variables within a desired range. Closed-loop therapeutics therefore begin to merge diagnosis, treatment and prevention within the same living platform. Across metabolism, inflammation, infection, cardiovascular regulation and cancer, early mammalian systems show that endogenous sensing, intracellular computation and therapeutic actuation can be combined in clinically relevant architectures. The emerging concept of setpoint medicine captures the clinical ambition of these systems: not simply to deliver a dose, but to keep physiology within an interpretable and therapeutically desirable range. Realizing this vision will require durable and modular control circuits, hardware-aware delivery strategies, interpretable safety frameworks, controller-style performance metrics and increasingly AI-assisted design, calibration and oversight. If these challenges can be met, the future of therapy may be defined less by intermittent dosing than by the continuous control of physiology.

Authors

Publication Details

Journal
Signal Transduction and Targeted Therapy
Published
2026-11-17
DOI
https://doi.org/10.1038/s41392-026-03122-4
Primary Topic
Gene Regulatory Network Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Engineering signal transduction for closed-loop gene and cell therapies

Martin Fussenegger, Haifeng Ye
Signal Transduction and Targeted Therapy
Gene Regulatory Network Analysis
article

Engineering signal transduction for closed-loop gene and cell therapies

Martin Fussenegger, Haifeng Ye
article en

Abstract

Abstract Chronic diseases are still treated largely with interventions that are constitutive, intermittently administered and poorly aligned with real-time physiology. Synthetic biology is changing this paradigm by treating gene circuits as programmable genetic software that can be deployed across cellular therapeutic hardware spanning from prokaryotic to eukaryotic systems, including probiotic cells, designer cells, immune cells and stem‑cell‑derived platforms. In this framework, engineered systems can sense disease-associated signals, compute them through synthetic or repurposed transduction pathways and adjust therapeutic output to maintain physiological variables within a desired range. Closed-loop therapeutics therefore begin to merge diagnosis, treatment and prevention within the same living platform. Across metabolism, inflammation, infection, cardiovascular regulation and cancer, early mammalian systems show that endogenous sensing, intracellular computation and therapeutic actuation can be combined in clinically relevant architectures. The emerging concept of setpoint medicine captures the clinical ambition of these systems: not simply to deliver a dose, but to keep physiology within an interpretable and therapeutically desirable range. Realizing this vision will require durable and modular control circuits, hardware-aware delivery strategies, interpretable safety frameworks, controller-style performance metrics and increasingly AI-assisted design, calibration and oversight. If these challenges can be met, the future of therapy may be defined less by intermittent dosing than by the continuous control of physiology.

Signal Transduction and Targeted TherapyVol. 11(1)
Gene Regulatory Network Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon